Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19

An exacerbated and unbalanced immune response may account for the severity of COVID-19, the disease caused by the novel severe acute respiratory syndrome (SARS) coronavirus 2, SARS-CoV-2. In this Viewpoint, we summarize recent evidence for the role of neutrophils in the pathogenesis of COVID-19 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Koenig, Lars M., Boehmer, Daniel F.R., Metzger, Philipp, Schnurr, Max, Endres, Stefan, Rothenfusser, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365736/
https://www.ncbi.nlm.nih.gov/pubmed/32678432
http://dx.doi.org/10.1084/jem.20201342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365736/
https://www.ncbi.nlm.nih.gov/pubmed/32678432
http://dx.doi.org/10.1084/jem.20201342

Ejemplares similares